IceCure Medical Ltd. (ICCM)
↓ Download CSV- Sector Manufacturing
- Incorporated L3
- Fiscal year ends Dec 31
In fiscal 2025, IceCure Medical Ltd. reported revenue of $3.38M, up 2.7% from the prior year. The company ran a net loss, with a net margin of -445.6% and a gross margin of 36.3%.
Key ratios (FY2025)
36.3%
Gross margin
-446.7%
Operating margin
-445.6%
Net margin
-166.4%
Return on equity
+2.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $3.38M | $3.29M | $3.23M | $3.08M | $4.14M | $3.87M | $1.63M |
| Cost of Revenue | $2.15M | $1.84M | $1.93M | $1.64M | $1.94M | $1.42M | $1.10M |
| Gross Profit | $1.23M | $1.45M | $1.30M | $1.45M | $2.19M | $2.44M | $524.0K |
| Operating Income | -$15.09M | -$15.70M | -$15.58M | -$16.74M | -$9.72M | -$4.14M | -$4.78M |
| Net Income | -$15.06M | -$15.32M | -$14.65M | -$16.98M | -$9.89M | -$3.73M | -$4.55M |
| EPS (Diluted) | $0.24 | $0.30 | $0.32 | $0.46 | $0.35 | $0.22 | $0.33 |
| Total Assets | $13.89M | $12.58M | $16.41M | $30.19M | $32.28M | $10.24M | — |
| Shareholders' Equity | $9.05M | $6.90M | $12.16M | $25.42M | $26.96M | $5.65M | $3.29M |
| Cash & Equivalents | $8.90M | $7.56M | $10.53M | $23.66M | $25.62M | $3.50M | — |
| Operating Cash Flow | -$14.57M | -$12.56M | -$12.55M | -$14.29M | -$12.61M | -$3.69M | -$1.99M |
| Capital Expenditures | $36.0K | $71.0K | $480.0K | $891.0K | $533.0K | $223.0K | $103.0K |
| Shares Outstanding | 63.58M | 50.88M | 45.64M | 37.02M | 28.55M | 17.13M | 13.62M |